Building up an IP portfolio, orphan designations and progressing the products in the pipeline will bring the value. I've been following the company fairly closely and was surprised when I assembled it all. Hard to remember what happened last week let alone the last 12 months.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links